EMSELEX

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, Germany, Ireland, Lithuania, Mexico, Netherlands, Poland, Romania, Turkey, UK.

Active ingredients

The drug EMSELEX contains one active pharmaceutical ingredient (API):

1	Darifenacin UNII CR02EYQ8GV - DARIFENACIN HYDROBROMIDE
	Darifenacin is a selective muscarinic M3 receptor antagonist (M3 SRA) in vitro. The M3 receptor is the major subtype that controls urinary bladder muscle contraction. It is not known whether this selectivity for the M3 receptor translates into any clinical advantage when treating symptoms of overactive bladder syndrome.
	Read more about Darifenacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMSELEX Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD10	Darifenacin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01754876, 01754899, 01754913, 01754994, 01755002, 01755019, 17421906, 17631118
EE	Ravimiamet	1199998, 1200003, 1200014, 1200025, 1200036, 1200047, 1200058, 1200069, 1200070, 1200081, 1200092, 1200104, 1200115, 1200126
FI	Lääkealan turvallisuus- ja kehittämiskeskus	023047, 023124, 023146, 023193
GB	Medicines & Healthcare Products Regulatory Agency	109681, 109684, 367990, 367992, 374358, 374360, 376344, 376346, 381328, 381330
LT	Valstybinė vaistų kontrolės tarnyba	1027975, 1027976, 1027977, 1027978, 1027979, 1027980, 1027981, 1027982, 1027983, 1027984, 1027985, 1027986, 1063750, 1063751, 1070290, 1070291, 1070292, 1070293, 1070294, 1070295, 1070296, 1070297, 1070298, 1070299, 1070300, 1070301, 1070302, 1070303
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	612M2005
NL	Z-Index G-Standaard, PRK	78204, 78212
PL	Rejestru Produktów Leczniczych	100129630, 100129647
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66045001, W66045002, W66045003, W66045004, W66045005, W66045006, W66046001, W66046002, W66046003, W66046004, W66046005, W66046006
TR	İlaç ve Tıbbi Cihaz Kurumu	8699874080120, 8699874080137